---
pmid: '29193663'
title: Clinical and genetic characterization of AP4B1-associated SPG47.
authors:
- Ebrahimi-Fakhari D
- Cheng C
- Dies K
- Diplock A
- Pier DB
- Ryan CS
- Lanpher BC
- Hirst J
- Chung WK
- Sahin M
- Rosser E
- Darras B
- Bennett JT
- CureSPG47
journal: Am J Med Genet A
year: '2018'
full_text_available: false
doi: 10.1002/ajmg.a.38561
---

# Clinical and genetic characterization of AP4B1-associated SPG47.
**Authors:** Ebrahimi-Fakhari D, Cheng C, Dies K, Diplock A, Pier DB, Ryan CS, Lanpher BC, Hirst J, Chung WK, Sahin M, Rosser E, Darras B, Bennett JT, CureSPG47
**Journal:** Am J Med Genet A (2018)
**DOI:** [10.1002/ajmg.a.38561](https://doi.org/10.1002/ajmg.a.38561)

## Abstract

1. Am J Med Genet A. 2018 Feb;176(2):311-318. doi: 10.1002/ajmg.a.38561. Epub
2017  Nov 28.

Clinical and genetic characterization of AP4B1-associated SPG47.

Ebrahimi-Fakhari D(1)(2), Cheng C(3), Dies K(1), Diplock A(1), Pier DB(1)(4), 
Ryan CS(5), Lanpher BC(6), Hirst J(7), Chung WK(8), Sahin M(1), Rosser E(9), 
Darras B(1), Bennett JT(10); CureSPG47.

Author information:
(1)Department of Neurology, Boston Children's Hospital, Harvard Medical School, 
Boston, Massachusetts.
(2)Division of General Pediatrics, Boston Children's Hospital, Harvard Medical 
School, Boston, Massachusetts.
(3)Center for Integrative Brain Research, Seattle Children's Research Institute, 
Seattle, Washington.
(4)Department of Neurology, Massachusetts General Hospital, Boston, 
Massachusetts.
(5)Department of Child and Adolescent Neurology, Mayo Clinic, Rochester, 
Minnesota.
(6)Department of Clinical Genomics, Mayo Clinic, Rochester, Minnesota.
(7)Cambridge Institute for Medical Research, University of Cambridge, 
Addenbrooke's Hospital, Cambridge, UK.
(8)Department of Pediatrics and Medicine, Columbia University Medical Center, 
New York, New York.
(9)Department of Clinical Genetics, Great Ormond Street Hospital for Children 
NHS Foundation Trust, London, UK.
(10)Center for Developmental Biology and Regenerative Medicine, Seattle 
Children's Research Institute, and Division of Genetic Medicine, Department of 
Pediatrics, University of Washington, Seattle, Washington.

The hereditary spastic paraplegias (HSPs) are a heterogeneous group of disorders 
characterized by degeneration of the corticospinal and spinocerebellar tracts 
leading to progressive spasticity. One subtype, spastic paraplegia type 47 
(SPG47 or HSP-AP4B1), is due to bi-allelic loss-of-function mutations in the 
AP4B1 gene. AP4B1 is a subunit of the adapter protein complex 4 (AP-4), a 
heterotetrameric protein complex that regulates the transport of membrane 
proteins. Since 2011, 11 individuals from six families with AP4B1 mutations have 
been reported, nine of whom had homozygous mutations and were from 
consanguineous families. Here we report eight patients with AP4B1-associated 
SPG47, the majority born to non-consanguineous parents and carrying compound 
heterozygous mutations. Core clinical features in this cohort and previously 
published patients include neonatal hypotonia that progresses to spasticity, 
early onset developmental delay with prominent motor delay and severely impaired 
or absent speech development, episodes of stereotypic laughter, seizures 
including frequent febrile seizures, thinning of the corpus callosum, and 
delayed myelination/white matter loss. Given that some of the features of AP-4 
deficiency overlap with those of cerebral palsy, and the discovery of the 
disorder in non-consanguineous populations, we believe that AP-4 deficiency may 
be more common than previously appreciated.

Â© 2017 Wiley Periodicals, Inc.

DOI: 10.1002/ajmg.a.38561
PMID: 29193663 [Indexed for MEDLINE]
